IGC

AMEX · Pharmaceuticals

Igc Pharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.20

+0.01 (+5.82%)

As of Nov 7, 2:43 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +7,720.0% upside

Low Target $13.90

Average Target $15.64

High Target $22.29

Current Price $0.20

Current
$0.20

Target
$15.64

$13.90 $15.64 avg $22.29

Scenario Analysis

Bear Case

$13.90

6,850.0%

Low target

Base Case

$15.64

+7,720.0%

Avg target

Bull Case

$22.29

+11,045.0%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$0.40

-50.5% from high

52-Week Low

$0.08

+150.0% from low

Target vs 52W High

$15.64

+3,770.3% vs high

Next Earnings Report

Nov 18, 2026

10d

until earnings

EPS Est: $-0.02

Earnings in 10 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+164.3%